In a recent meta-analysis, Xin Tao and colleagues examined the capability of omega-3 polyunsaturated fatty acids (PUFAs) ... Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ... A study published in JAMA Oncology found that a contralateral esophagus-sparing technique reduces the risk of severe ... Frontline tislelizumab plus chemotherapy significantly improved progression-free survival (primary endpoint) compared ... The U.S. Food and Drug Administration approved Imfinzi® (durvalumab) in combination with etoposide plus either ... A phase I/II study published in JAMA Oncology found that the HIV protease inhibitor Viracept® (nelfinavir mesylate) ... The U.S. Food and Drug Administration (FDA) approved atezolizumab in combination with carboplatin and etoposide for ... A recent study published in the journal Lung Cancer evaluated the effects of lung cancer nurse specialists (LCNSs) on ... A study published in the journal Menopause found that among women who received chemotherapy for lung cancer ... The novel agent tislelizumab improved progression-free survival (PFS; primary endpoint) in the firstline setting in ...